Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lagercrantz Group AB in connection with its acquisition of Prido AB
Mandate

Vinge advises Lagercrantz Group AB in connection with its acquisition of Prido AB

February 07, 2024 Employment and Benefits Capital Markets and Public M&A IT, Telecommunications and Outsourcing Intellectual Property Data protection and processing of personal data Real Estate and Construction EU, Competition and Regulatory

Vinge advises Lagercrantz Group AB in connection with its acquisition of 96% of the shares in Prido AB. Prido AB was founded in 1973 and is today one of Europe's largest manufacturers of high-quality industrial folding doors, with an annual revenue of approximately SEK 300 million. The transaction is subject to approval by the relevant authorities and is expected to close in March 2024.

Vinge's team consisted of Johan Winnerblad, Clara Sohlberg and Filip Magnusson (M&A), Victor Björkheim (Employment), Ellis Allmark (Agreements), Sofia Bergenståhle (IPR), Johan Cederblad, Karolina Cohrs and Madelene Andersson (Real Estate and environment), Ida Redander (Finance), Alva Chambert (Competition) and Arthur Kinski (IT/GDPR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025